(Q42688462)

English

An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure

scientific article published on 21 February 2013

Statements

An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure (English)
Marc S Penn
Farrell O Mendelsohn
Gary L Schaer
Warren Sherman
Maryjane Farr
Joseph Pastore
Didier Rouy
Ruth Clemens
Rahul Aras
Douglas W Losordo
21 February 2013
816-825

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit